Volume 22, Number 3—March 2016
Online Report
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
Table 3
National TB program director | Implementing partner | Technical assistance provider | Donor | Advocacy group |
---|---|---|---|---|
Belarus |
Global Drug Facility |
Clinton Foundation |
Global Fund for AIDS, TB, and Malaria |
Global Coalition of TB Activists |
India |
Management Sciences for Health/Systems for Improved Access to Pharmaceutical and Services |
UNITAID |
Global TB Community Advisory Board |
|
Russian Federation |
KNCV Tuberculosis Foundation |
Stop TB Partnership |
US Agency for International Development |
|
South Africa |
Médecins Sans Frontières |
Society Working on Implementation to Fight TB Response Project |
Moldovan Society Against Tuberculosis |
|
Vietnam |
Partners in Health |
World Health Organization |
RESULTS UK |
|
Treatment Action Campaign |
||||
Treatment Action Group |
||||
*DR, drug-resistant; STAT, Scale-up Treatment Action Team; TB, tuberculosis. |
Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.